ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.

Shweta Kotian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.